"Medical Journeys" chart a path each step of the way for ... as the caregiver team navigates the course of a disease. For Alzheimer's disease, early identification has been a long-sought goal.

For Alzheimer's disease, the progression is predictable ... both a physician guide and a downloadable/printable patient ...

If you've been looking for a sign to work on your sleep hygiene, this is it. A new study suggests that a particular wave of ...

Readers disagree with a guest essay urging mandatory reporting of impaired drivers. Also: The power of plutocrats; a suicide ...

Aging brings many changes that can be unpleasant, from losing mobility to needing help with tasks that used to be easy. For those with Alzheimer's disease and other forms of ...

A compassionate, multidisciplinary approach can help manage one of the most complex challenges nursing homes and other long-term care providers face.

Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.

AbbVie (ABBV) reports Q3 earnings Wednesday. The acquisition of Aliada Therapeutics may boost its Alzheimer's portfolio and ...

Today, Benzinga's options scanner spotted 8 options trades for Cassava Sciences. This isn't normal. The overall sentiment of ...

Eli Lilly has been making quite a bit of noise thanks to its work in diabetes and obesity. Investors turned on the company, ...

As the chart above illustrates ... Lilly will face more competition in the eczema market than it will in Alzheimer's disease, Ebglyss does present a unique opportunity for the company.

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier (the filter that protects the brain from harmful substances), experiments ...